Gabelli & Co Investment Advisers’s Elevance Health ELV Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-600	Closed	-$233K	–	293
2025 Q2	$233K	Hold	600	–	–	0.04%	205
2025 Q1	$261K	Hold	600	–	–	0.04%	177
2024 Q4	$221K	Hold	600	–	–	0.04%	188
2024 Q3	$312K	Hold	600	–	–	0.05%	132
2024 Q2	$325K	Hold	600	–	–	0.05%	156
2024 Q1	$311K	Buy	600 +100	+20%	+$49.7K	0.05%	148
2023 Q4	$236K	Hold	500	–	–	0.04%	166
2023 Q3	$218K	Hold	500	–	–	0.04%	172
2023 Q2	$222K	Buy	+500	New	+$231K	0.04%	169
2020 Q4	–	Sell	-750	Closed	-$201K	–	334
2020 Q3	$201K	Buy	+750	New	+$202K	0.04%	181
2020 Q1	–	Sell	-750	Closed	-$227K	–	198
2019 Q4	$227K	Buy	+750	New	+$206K	0.03%	154
2019 Q3	–	Sell	-750	Closed	-$212K	–	188
2019 Q2	$212K	Hold	750	–	–	0.02%	159
2019 Q1	$215K	Buy	+750	New	+$217K	0.03%	138

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Gabelli & Co Investment Advisers's ELV Position: Q3 2025 in Review

Gabelli & Co Investment Advisers sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 600 shares — an estimated $233K sold.

Gabelli & Co Investment Advisers first reported a position in ELV in Q1 2019 and held it in 13 quarters. The position peaked at $325K in Q2 2024. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Gabelli & Co Investment Advisers reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 600 Elevance Health shares in Q3 2025, an estimated $233K.
Gabelli & Co Investment Advisers first reported a position in Elevance Health in Q1 2019 and held it in 13 quarters.
Gabelli & Co Investment Advisers's Elevance Health position peaked at $325K in Q2 2024.
1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.